Two Sigma Advisers’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Two Sigma Advisers’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-186	Closed	-$21K	–	2716
2021 Q2	$21K	Sell	186 -291	-61%	-$33.8K	﹤0.01%	2410
2021 Q1	$59K	Sell	477 -192	-29%	-$26.8K	﹤0.01%	2490
2020 Q4	$68K	Buy	669 +6	+0.9%	+$708	﹤0.01%	2300
2020 Q3	$110K	Buy	+663	New	+$138K	﹤0.01%	2265

Other funds holding QNTM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Resource Management Metairie, Louisiana $970M AUM 28.05% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's QNTM Position: Q3 2021 in Review

Two Sigma Advisers sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2021, closing a stake of 186 shares — an estimated $21K sold.

Two Sigma Advisers first reported a position in QNTM in Q3 2020 and held it in 4 quarters. The position peaked at $110K in Q3 2020. 17 funds tracked by Wall St. Rank hold QNTM as of Q3 2021.

Two Sigma Advisers reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2021 after selling out during the quarter.
Two Sigma Advisers sold 186 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2021, an estimated $21K.
Two Sigma Advisers first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2020 and held it in 4 quarters.
Two Sigma Advisers's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $110K in Q3 2020.
17 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.